Main caricature of Julie Collens, who is speaking at HLTH and is CEO at Vivid Genomics Overlay caricature of Julie Collens, who is speaking at HLTH and is CEO at Vivid Genomics

Julie Collens

CEO

Vivid Genomics

Julie Collens, PhD, is the CEO of Vivid Genomics. She received a BSc from University of Calgary and PhD in evolutionary population genetics from the University of Chicago. Following her academic career, she was a sell-side equity analyst covering life science tools and molecular diagnostics companies at Robert W Baird and was most recently Associate Director of Market Development at Illumina, developing and driving strategies to accelerate the clinical application of genomics in complex diseases, with a particular focus on neurodegenerative disease. At Vivid Genomics, she is leveraging a combined experience in genomics, finance, business development, strategy, and commercialization to identify efficient approaches to improving neurodegenerative drug development.

See All Speakers

Some additional speakers you may like

Assistant to the President and Director of the Domestic Policy Council
The White House
Acting Chairman of the Council of Economic Advisers
The White House
Administrator
Centers for Medicare & Medicaid Services
Deputy Secretary
Health & Human Services